Why the study?
Small-conductance (SK) calcium-activated potassium channels are a promising target in AF, but functional properties differentiating SK inhibitors remain poorly understood.
Apamin and AP14145 inhibit SK channels by inducing very long channel closures, but exhibit distinct effects on gating kinetics and unitary current amplitude, which may explain their functional differences in vivo.
Does not support clinical use of SK inhibitors; extends biophysical understanding of inhibition but leaves open therapeutic translation in AF.
Small-conductance (SK) calcium-activated potassium channels are a promising treatment target in atrial fibrillation. However, the functional properties that differentiate SK inhibitors remain poorly understood. The objective of this study was to determine how two unrelated SK channel inhibitors, apamin and AP14145, impact SK channel function in excised inside-out single-channel recordings. Surprisingly, both apamin and AP14145 exert much of their inhibition by inducing a class of very-long-lived channel closures (apamin: τ c,vl = 11.8 ± 7.1 s, and AP14145: τ c,vl = 10.3 ± 7.2 s), which were never observed under control conditions. Both inhibitors also induced changes to the three closed and two open durations typical of normal SK channel gating. AP14145 shifted the open duration distribution to favor longer open durations, whereas apamin did not alter open-state kinetics. AP14145 also prolonged the two shortest channel closed durations (AP14145: τ c,s = 3.50 ± 0.81 ms, and τ c,i = 32.0 ± 6.76 ms versus control: τ c,s = 1.59 ± 0.19 ms, and τ c,i = 13.5 ± 1.17 ms), thus slowing overall gating kinetics within bursts of channel activity. In contrast, apamin accelerated intraburst gating kinetics by shortening the two shortest closed durations ( τ c,s = 0.75 ± 0.10 ms and τ c,i = 5.08 ± 0.49 ms) and inducing periods of flickery activity. Finally, AP14145 introduced a unique form of inhibition by decreasing unitary current amplitude. SK channels exhibited two clearly distinguishable amplitudes (control: A high = 0.76 ± 0.03 pA, and A low = 0.54 ± 0.03 pA). AP14145 both reduced the fraction of patches exhibiting the higher amplitude (AP14145: 4/9 patches versus control: 16/16 patches) and reduced the mean low amplitude (0.38 ± 0.03 pA). Here, we have demonstrated that both inhibitors introduce very long channel closures but that each also exhibits unique effects on other components of SK gating kinetics and unitary current. The combination of these effects is likely to be critical for understanding the functional differences of each inhibitor in the context of cyclical Ca 2+ -dependent channel activation in vivo.
No takes yet. Share an insight, caveat, or question.
Herck et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: